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Abstract
Glucose-6-phosphate  (G6P)  is  an  enzyme
in the hexose monophosphate shunt required
for  the  production  of  reducing  equivalents
needed to mop up free radicals. thereby keep-
ing hemoglobin in its free state. Deficiency of
the enzyme can cause severe neonatal jaun-
dice. The aim of this study was to compare
G6PD levels in pre-term and term babies, and
evaluate the extent to which G6PD deficiency
determines the severity of jaundice in various
gestational age groups. Samples of cord blood
collected from consecutively delivered babies
in the University of Ilorin Teaching Hospital,
Nigeria, were assayed for G6PD levels, and
the babies were observed for jaundice during
the first week of life. Those who developed
jaundice  had  serial  serum  bilirubin  meas-
ured.  Nine  hundred  and  thirty-three  babies
had G6PD assayed, with 348 being G6PD defi-
cient, giving a hospital based prevalence of
37.3%. Of the 644 who were followed up, 143
(22.2%) were pre-term and 501(77.8%) were
term babies. Babies with gestational age (GA)
27-29  weeks  had  the  highest  G6PD  levels.
However, there was no significant variation
among  the  different  gestational  age  groups
(F=0.64, P=0.64). Jaundice occurred more in
pre-term compared to term babies with a rel-
ative  risk  of  2.41  (ˇ2=60.95,  P=0.00001).
Occurrence  of  jaundice  in  pre-term  babies
was  irrespective  of  G6PD  status  (ˇ2=0.2,
P=0.66, RR=1.09, CI=0.83<RR<1.43). There
is an inverse relationship between gestation-
al age and the occurrence of jaundice (R2=-
0.874).  Pre-term  babies  are  more  likely  to
have higher G6PD levels, but occurrence of
jaundice in pre-term babies is irrespective of
G6PD status. More severe jaundice (especial-
ly for gestational age) occurring in pre-term
babies requires critical care.
Introduction
Glucose-6-phosphate  dehydrogenase
(G6PD)  is  an  enzyme  in  the  hexose
monophosphate shunt that catalyzes the oxi-
dation of glucose-6-phoshate to 6-phosphoglu-
conate while concomitantly reducing the oxi-
dised  form  of  nicotinamide  adenide  dinu-
cleotide phosphate (NADP+) to NADPH.1 The
NADPH, a required co-factor in many biosyn-
thetic reactions, maintains glutathione in its
reduced form. Reduced glutathione acts as a
scavenger  for  free  radicals,  and  thus  helps
reduce oxidized hemoglobin to free hemoglo-
bin; otherwise oxidized hemoglobin will pre-
cipitate as Heinze bodies.2,3
G6PD deficiency is the most common enzy-
mopathy-producing  disease  in  humans.1
Inherited as an X-linked recessive disorder, it
affects about 400 million people worldwide.3 In
Nigeria, an estimated 22% of the male popula-
tion  is  said  to  have  G6PD  deficiency.4 In
neonates  in  Nigeria,  figures  in  jaundiced
babies range from 35.3%5 to 61.5%6.
Studies from this part of the world repeated-
ly  show  that  babies  with  G6PD  deficiency
develop worse forms of jaundice that require
exchange transfusions, or that may even lead
to kernicterus.5-10 There is, however, no docu-
mentation correlating enzyme levels with ges-
tational age. Therefore, this study aims to com-
pare  the  G6PD  levels  in  pre-term  and  term
babies, and the effect of their enzyme levels on
the severity of jaundice.
Materials and Methods
This cross sectional prospective study was
carried  out  aon  the  Labor  ward  and  the
Neonatal Intensive Care Unit of the University
of  Ilorin  Teaching  Hospital  (UITH),  Nigeria,
with the approval of the institutional Ethical
Review Committee. Average yearly admissions
range from 4,500-5,000 babies, with virtually
all babies being of West African descent.
Consecutively  delivered  newborn  babies
were recruited into the study. Exclusion crite-
ria included asphyxia, extravascular blood loss,
polycytemia, evidence of septicemia, congeni-
tal malformations, babies with GA 42 weeks or
over,  babies  of  mothers  with  blood  group  O
Rhesus antigen positive, and exposure to ante-
natal phenobarbitone.
At  delivery,  following  resuscitation,  blood
from  the  placental  end  of  the  cut  cord  was
drawn and G6PD levels were assayed using an
in vitro diagnostic kit manufactured by RAN-
DOX© Laboratories Limited (Co. Antrim, UK).
Babies were then classified as appropriate for
gestational  age  (AGA),  small  for  gestational
age (SGA) and large for gestational age (LGA)
using the intrauterine growth charts described
by Lubchenco,11 which are those used in the
Neonatal Intensive Care Unit, UITH.
Gestational age was calculated from the last
menstrual period (LMP); this remains the gold
standard. When LMP was indeterminate, a first
trimester ultrasound was used. When gesta-
tional age could not be determined by either
LMP or first trimester ultrasound, a neurologi-
cal  and  physical  maturity  rating  chart
(Ballard12 chart) was employed. 
Babies were observed on a daily basis for
jaundice during the first week of life. Mothers
had previously been educated on how to exam-
ine for jaundice and on the dangers of neona-
tal hyperbilirubinemia, and on the importance
of avoiding commonly available oxidants, such
as  naphthalene  balls,  methyl  salicylate  con-
taining ointments, local concoctions (most of
which are brewed with naphthalene), and a
commonly  available  powder,  Moju  powder,
which contains camphor and is used to cure
babies’ skin ailments. Mobile phone numbers
of the baby’s care givers’ (preferably the moth-
er’s)  had  been  collected  and  mothers  were
reminded about their baby’s appointment by
phone. Some babies remained in the nursery
during the duration of the period they needed
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to be followed up as the mothers were still on
the ward (e.g. following Caeserian section or
following delivery complications).
Serum bilirubin of all babies was analyzed
as required for correct management. Babies
whose  serum  bilirubin  values  were  higher
than those accepted as normal on the Bhutani
normogram13 were managed according to the
standard  protocol  of  the  Neonatal  Intensive
Care Unit. This is in line with the guidelines
set by the American Academy of Pediatrics.14
Laboratory methods
For G6PD assay, 2 mL of blood drawn from
the placental end of the cord were collected
into EDTA containing bottles within the first
hour  of  delivery.  Enzyme  level  was  assayed
using a quantitative in vitro test (RANDOX©).
Red blood cell G6PD value of 2.9 U/gHb or over
was considered as normal.
Plasma bilirubin (total and conjugated) was
determined using the method of Malloy and
Evelyn.15
Data analysis
Data analysis was carried out using EPI-info
version 6 software.16 Association between cat-
egorical  variables  was  tested  using  ˇ2 test.
Relationship  between  a  continuous  variable
and  dependent  variable  were  tested  using
Student’s t-test or ANOVA as appropriate. 
For all statistical analysis, P <0.05 was con-
sidered significant. 
Results
Study population
The study was conducted over a 10-month
period during which there were 4,591 deliver-
ies on the Labor ward of the UITH. There were
2,525 males and 2,066 females with a male to
female ratio of 1.1:1. Gestational age of babies
ranged from 26 weeks to 44 weeks with a mean
of 39±3.9 weeks. Birth weight ranged from 700-
5,450 gr with a mean of 3513±1315.2 gr. Nine
hundred  and  thirty-three  babies  had  G6PD
enzyme assay performed shortly after birth, but
289 were eventually excluded for various rea-
sons, such as early pre-term death, PCV over
64%,  full  blood  count  results  that  eventually
were suggestive of sepsis, eventual evidence of
extravascular blood loss, babies of blood group
O  Rhesus  positive  mothers,  and  incomplete
results. Six hundred and forty-four babies were
followed up till the end of the study. 
The gestational age (GA) of the babies stud-
ied ranged from 27-42 weeks with a mean GA
of 38±2.7 weeks. Five hundred and thirty-six
babies  (83.2%)  were  appropriate  for  GA;  59
(9.2%)  were  small  for  GA,  while  49  (7.6%)
were large for gestational age.
Glucose-6-phosphate
dehydrgenase levels 
Table 1 shows the mean G6PD levels in rela-
tion to gestational age. Babies with gestation-
al age between 27-29 weeks had the highest
G6PD values (5.10±4.99 U/gHb), followed by
babies with gestational age (GA) 30-33 weeks
(4.23±2.5  U/gHb).  Post-term  babies  had  the
lowest  G6PD  values  of  the  groups  (3.7±2.4
U/gHb). Overall, there was no statistically sig-
nificant difference in G6PD levels among the
gestational age groups (F=0.64, P=0.64).
Prevalence of Jaundice in relation
to gestational age
Eighty-six (61%) pre-term babies compared
to 125 (25%) term babies developed jaundice
(Table 2) and the difference was statistically
significant  (ˇ2=60.95,  P=0.00001,  RR=2.41,
CI=1.97<RR<2.95). Pre-term babies were two
and half times more likely to develop jaundice
as the term newborns. This relationship is fur-
ther supported by data showing an inverse rela-
tionship between gestational age and the devel-
opment of jaundice (Figure 1). With an R2 of
0.874, the predictive ability of gestational age
indicating the possible occurrence of jaundice
was high; it can be predicted with certainty that
the younger the gestational age, the more like-
ly it would be for a baby to have jaundice.
Relationship between jaundice and
gestational age with respect to
glucose-6-phosphate
dehydrgenase level
We analyzed the presence of G6PD deficien-
cy among jaundiced pre-term and term babies
(Table  2).  Jaundice  occurred  in  33  (63.5%)
pre-term babies who were G6PD deficient and
in  53  (58.2%)  of  pre-term  babies  who  were
G6PD normal (P=0.66); however, this differ-
ence was not statistically significant.
Among the term babies, jaundice occurred in
78 (41.5%) babies who were G6PD deficient but
in 47 (15% ) of G6PD normal babies; the differ-
ence  was  significantly  different  (ˇ2=24.3,
P=0.0000008,  RR=2.25,  CI=1.62<RR<3.11)
with the chances of a G6PD deficient term baby
developing jaundice being twice that of a G6PD
normal term baby.
Treatment of jaundice
The need to institute treatment for jaundice,
and the methods used, was based on the child’s
GA, chronological age in hours and existing co-
morbidities. As is the unit’s policy, however,
pre-term babies with GA less than 34 weeks by
default  begin  phototherapy  within  24  h  of
birth. This is a pre-emptive strategy and has
been  found  to  reduce  the  incidence  of
exchange  blood  transfusions  performed  on
this set of babies.
Table 3 shows the average duration of pho-
totherapy,  and  number  of  exchange  blood
transfusions for each gestational age group.
Babies with GA between 27-29 weeks spent
the longest duration of time under photothera-
py. Length of time spent under phototherapy
progressively decreased with increasing gesta-
tional age and the difference was statistically
significant (F=123.34, P=0.000).
No baby developed or died from acute biliru-
bin encephalopathy during this study.
Discussion
In this study, glucose-6-phosphate dehydro-
genase levels were found to be higher in pre-
term babies than term babies, but this was not
statistically significant. A review of the work of
other  researchers17,18 showed  that  pre-term
babies usually have significantly higher G6PD
Article
Figure 1. Relationship between gestational age and proportion of babies with jaundice.[Pediatric Reports 2012; 4:e7] [page 23]
levels. The small cohort of pre-term babies, as
compared to the number of term babies, fol-
lowed up till the end of the study could explain
why the higher G6PD levels in pre-term babies
were not statistically significant. 
A  higher  G6PD  enzyme  level  in  pre-term
neonates may be due to the fact that the pre-
term  baby  has  immature  hemopoietic  cell
lines.19 An assay of immature red blood cells
would naturally yield higher enzyme levels.20
Sixty-one  percent  of  the  pre-term  babies
developed neonatal jaundice compared to 25%
of term babies. This was expected and the dif-
ference was statistically significant. These fig-
ures  are  lower  than  those  previously  docu-
mented in other studies: 71.2%21 and 80%22 of
pre-term babies, and 60%22 of term babies. The
pre-term baby is less mature and less able to
handle a bilirubin load. Therefore, not only do
pre-term babies have a higher level of serum
bilirubin  for  gestational  age,  but  they  have
jaundice for longer period of time.13,19,22,23 The
pre-term baby’s inability to handle a bilirubin
load arises primarily from the immaturity of
their conjugating enzyme systems. While the
UDPGT activity of a term baby functions at 1%
of adult values, the baby with a GA of under 34
weeks has an UDPGT activity that functions at
less  than  0.01%.24,25 In  addition  to  this,
intrauterine  meconium  accumulation  in  the
gut  contains  approximately  100-200  mg  of
bilirubin per 100 g of meconium at birth, 50%
or  more  of  which  is  unconjugated.26 The
immaturity  of  the  pre-term  baby’s  enteric
innervations does not permit him to evacuate
meconium as early after delivery as the term
newborn. Therefore, with the full effect of the
enterohepatic circulation, the pre-term baby’s
bilirubin load increases.
An  inverse  relationship  was  observed
between  gestation  age  and  the  presence  of
jaundice  (R2=0.874).  Jaundice  occurred  in
100% of babies whose GA was between 27-29
weeks, with a consistent decline in the slope up
till the babies of GA 37-40 weeks. There was a
marginal rise in the frequency of occurrence of
jaundice  in  the  babies  with  a  GA  of  41-42
weeks. As described above, the pre-term baby is
expected to develop jaundice more frequently
and of greater severity than the term newborn. 
The cause of jaundice occurring in the pre-
term population was probably more a function
of their prematurity than of the G6PD deficien-
cy. Clinical jaundice was found to occur in 33
out of 52 (63.5%) of the pre-term babies who
were  G6PD  deficient  and  in  53  out  of  91
(58.2%)  of  pre-term  babies  who  were  G6PD
normal. In term babies, 47 out of 313 (15%) of
the G6PD normal babies developed jaundice,
compared with 78 out of 188 (41.5%) of the
G6PD  deficient  babies.  Earlier  results  from
this research have already shown that the ear-
lier pre-term babies are likely to have higher
G6PD  values.  It  is,  therefore,  not  surprising
that the occurrence of jaundice in the pre-term
babies is more a function of their premature
status (and thus by implication, immature con-
jugating systems) than it is of G6PD status.
The  lower  the  baby’s  gestational  age,  the
longer phototherapy will continue. Babies with
GA  27-29  weeks  spent  an  average  of
119.5±50.5 h on phototherapy, with babies GA
37-40  weeks  spending  the  least  number  of
hours on phototherapy. Despite the fact that
the earlier pre-term babies (GA ≤33 weeks)
made up only 8.54% of the study population,
they spent the longest time on phototherapy,
and  this  was  highly  statistically  significant
(F=123.34,  P=0.000).  The  long  time  spent
under phototherapy by the pre-term babies can
be explained by: i) the fact that the unit policy
is to start pre-term babies with GA less than 34
weeks on phototherapy, within 24 h of birth.
This policy is founded on local documentation
that has shown that this practice reduces the
need for exchange transfusions in this set of
babies;  ii)  as  discussed  above,  the  pre-term
baby is prone to develop a more severe jaun-
dice by virtue of her immaturity. A review of
existing literature did not report any compari-
son  between  the  duration  of  phototherapy
between term and pre-term babies.
No baby developed or died from acute biliru-
bin encephalopathy during this study.
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Table 3. Mean duration of phototherapy (SD) and number of EBT performed in each ges-
tational age group.
Gestational age N. Mean (SD) of N. babies
(weeks) phototherapy (hours) who had EBT performed
27-29 5 119.5±50.5 1
30-33 50 93.9±47.6 8
34-36 88 23.3±37.1 6
37-40 430 6.7±23.5 0
41-42 71 8.6±24.8 0
F=123.34, P=0.000
Table 1. Mean Glucose-6-phosphate dehydrogenase levels in relation to gestational age in
the total population studied.
Variable N. Deficient Normal G6PD level
(%) (&) (U/gHb)
(mean±SD)
Gestional age (weeks)
27-29 5 1 (20) 4 (80) 5.10±4.99
30-33 50 14 (28) 36 (72) 4.23±2.5
34-36 88 37 (42) 51(58) 4.1±2.4
37-40 430 163 (38) 267 (62) 4.0±2.5
41 – 42 71 25 (35.2) 46 (64.8) 3.7±2.4
F=0.64, P=0.64
Table 2. Relationship between gestational age, glucose-6-phosphate dehydrogenase level
and occurrence of jaundice.
Parameter Jaundice N. Jaundice ˇ2 P RR
(%) (%)
Gestational age
Pre-term (n=143) 86 (61%) 57 (39%)
Term (n=501) 125 (25%) 376 (75%) 60.95 0.00001 2.41
Gestational age and glucose-6-phosphate dehydrogenase status
27-36 weeks
deficient 33(63.5%) 19 (36.5%)
normal 53 (58.2%) 38 (41.8%) 0.19 0.66
37-42 weeks
deficient 78 (41.5%) 110 (58.5%)
normal 47 (15%) 266 (85%) 24.32 0.0000008[page 24] [Pediatric Reports 2012; 4:e7]
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